Sort   by:  
 Page size 
UnknownSmad4 is essential for epiblast scaling and morphogenesis after implantation, but nonessential before implantation.
Not available
S-EPMC11190579 | biostudies-literature
UnknownSmad4 is essential for epiblast scaling and morphogenesis after implantation, but nonessential prior to implantation in the mouse.
Not available
S-EPMC10849569 | biostudies-literature
UnknownThe advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.
Not available
S-EPMC4802157 | biostudies-literature
UnknownAssessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Not available
S-EPMC3235950 | biostudies-literature
UnknownLetrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
Not available
S-EPMC2921823 | biostudies-literature
UnknownEvaluation of appendicitis risk prediction models in adults with suspected appendicitis.
Not available
S-EPMC6972511 | biostudies-literature
UnknownColorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.
Not available
S-EPMC3641846 | biostudies-literature
UnknownMortality results from a randomized prostate-cancer screening trial.
Not available
S-EPMC2944770 | biostudies-literature
UnknownLow-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Not available
S-EPMC6587584 | biostudies-literature
UnknownLong-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Not available
S-EPMC3596060 | biostudies-literature
Sort   by:  
 Page size